KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Deferred Taxes (2016 - 2025)

Amgen (AMGN) has 13 years of Deferred Taxes data on record, last reported at -$19.0 million in Q4 2025.

  • For Q4 2025, Deferred Taxes rose 94.31% year-over-year to -$19.0 million; the TTM value through Dec 2025 reached -$721.0 million, up 41.29%, while the annual FY2025 figure was -$721.0 million, 41.29% up from the prior year.
  • Deferred Taxes reached -$19.0 million in Q4 2025 per AMGN's latest filing, up from -$30.0 million in the prior quarter.
  • Across five years, Deferred Taxes topped out at -$19.0 million in Q4 2025 and bottomed at -$623.0 million in Q4 2023.
  • Average Deferred Taxes over 5 years is -$243.6 million, with a median of -$250.5 million recorded in 2022.
  • Peak YoY movement for Deferred Taxes: tumbled 718.37% in 2024, then surged 94.31% in 2025.
  • A 5-year view of Deferred Taxes shows it stood at -$189.0 million in 2021, then tumbled by 85.71% to -$351.0 million in 2022, then plummeted by 77.49% to -$623.0 million in 2023, then skyrocketed by 46.39% to -$334.0 million in 2024, then soared by 94.31% to -$19.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Deferred Taxes were -$19.0 million in Q4 2025, -$30.0 million in Q3 2025, and -$422.0 million in Q2 2025.